Not Yet RecruitingNCT07766473
First in Human Study of BETA-TT8 in wetAge-related Macular Degeneration (wetAMD)
PHASE1 · PHASE2 · 24 planned enrolment
- Countries listed
- 1
- Registry update
- September 18, 2026
immortal.lifePublic trial registrations naming Filamon LTD as an industry lead sponsor.
This is an independent registry-name view, not a verified corporate profile, portfolio valuation, ownership map, endorsement, or investment recommendation.
This does not mean that no transaction exists. A record appears only after its disclosure source and the connection to this exact registry sponsor identity are separately verified.
PHASE1 · PHASE2 · 24 planned enrolment